Multiple sclerosis: an immune or neurodegenerative disorder?
By B. Trapp, K. Nave. Annual Review of Neuroscience, 2008
1,750 citations recorded by the source corpus.
Subfields: Neurology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/af27fb8c4623515417103c863338edb056b81f54
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
- Hans Lassmann
- K. Nave
- Wolfgang Brück
- C. Lucchinetti
- Robin J. M. Franklin
- B. Trapp
- C. ffrench-Constant
- R. Gerardy-Schahn
In Pathology and Forensic Medicine
- Hans Lassmann
- Wolfgang Brück
- K. Nave
- C. Lucchinetti
- Robin J. M. Franklin
- C. ffrench-Constant
- B. Trapp
- C. Iadecola
Citations in the corpus
- CNS-Resident Glial Progenitor/Stem Cells Produce Schwann Cells as well as Oligodendrocytes during Repair of CNS Demyelination (2010, neutral): “Failure of remyelination in progressive MS is associated with secondary axonal loss, which leads to the untreatable clinical deterioration that often characterizes late-stage MS (Trapp and Nave, 2008).”
- Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. (2009, background): “…be extensive in MS (Patrikios et al. 2006; Patani et al. 2007), it is an inconsistent event, and the accumulated load of lesions that fail to remyelinate in a timely manner contributes to irreversible axon loss and progressive neurological deterioration (Frohman et al. 2006; Trapp and Nave 2008).”
- Remyelination in the CNS: from biology to therapy (2008, background): “This is thought to be the major cause of this chronic progressive diseas”
- Mechanisms Underlying Inflammation in Neurodegeneration (2010, neutral): “The deposition of antibodies and complement around demyelinated lesions (Frohman et al., 2006) and axonal degeneration in the progression phase of MS have also been observed (Trapp and Nave, 2008).”
- Axon-glial signaling and the glial support of axon function. (2008, background): “The enormous plasticity of the brain may be able to mask a slowly progressive degeneration of the subcortical axons for a long time, and a substantial axonal loss may remain clinically silent in MS patients (Trapp & Nave 2008).”
- A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis (2011, background): “2324" language="eng" relation="no"> In multiple sclerosis, a common inflammatory disease of the central nervous system, immune-mediated axon damage is responsible for permanent neurological deficit”
- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis (2019, background): “In this situation PPMS could reflect the primary disease process of MS and the other courses (RRMS and SPMS) are those, modified by an inflammatory reaction (3).”
- Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. (2014, background): “Myelin nurtures the axons it enwraps, and when axon-myelin interactions are compromised, axons suffer (492).”